Economics And Clinical Evaluation Of Endovascular And Surgical Treatment Of Patients With Disability Of Superficial Femoral Artery

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68407700%3A21460%2F14%3A00221220" target="_blank" >RIV/68407700:21460/14:00221220 - isvavai.cz</a>

Výsledek na webu

<a href="http://dx.doi.org/10.1016/j.jval.2014.08.1402" target="_blank" >http://dx.doi.org/10.1016/j.jval.2014.08.1402</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.jval.2014.08.1402" target="_blank" >10.1016/j.jval.2014.08.1402</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Economics And Clinical Evaluation Of Endovascular And Surgical Treatment Of Patients With Disability Of Superficial Femoral Artery

Popis výsledku v původním jazyce

With the increasing price of modern instrumentation, it is appropriate to evaluate not only clinical efficiency, but also intervention economics. This study aims to create a recommendation for choosing the most effective treatment based on both economicdata and clinical outputs of the disabled superficial femoral artery. The methods chosen were reviewed from clinical outputs for treatment effectiveness, multiple-criteria decision-making for the synthesis of treatment effects, analysis of costs at the selected interventions and cost-effectiveness analysis. The four clinical outputs used in the study as a criterion by the research of the clinical studies were primary patency, technical success, patient survival and limb salvage at the year of operation.The weights of each criterion, and the preferences of the interventions were counted. The sequence of interventions was set by the AHP method: PTA (35.6%), PTA/S (33.9%) and bypass (30.6%) and method of weighted sum: PTA/S (56%), bypass

Název v anglickém jazyce

Economics And Clinical Evaluation Of Endovascular And Surgical Treatment Of Patients With Disability Of Superficial Femoral Artery

Popis výsledku anglicky

With the increasing price of modern instrumentation, it is appropriate to evaluate not only clinical efficiency, but also intervention economics. This study aims to create a recommendation for choosing the most effective treatment based on both economicdata and clinical outputs of the disabled superficial femoral artery. The methods chosen were reviewed from clinical outputs for treatment effectiveness, multiple-criteria decision-making for the synthesis of treatment effects, analysis of costs at the selected interventions and cost-effectiveness analysis. The four clinical outputs used in the study as a criterion by the research of the clinical studies were primary patency, technical success, patient survival and limb salvage at the year of operation.The weights of each criterion, and the preferences of the interventions were counted. The sequence of interventions was set by the AHP method: PTA (35.6%), PTA/S (33.9%) and bypass (30.6%) and method of weighted sum: PTA/S (56%), bypass

Druh

O - Ostatní výsledky

CEP obor

AE - Řízení, správa a administrativa

OECD FORD obor

—

Projekt

<a href="/cs/project/NT11532" target="_blank" >NT11532: Hodnocení zdravotnických prostředků</a><br>

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2014

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů